Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / @xirurgi_2025 / @xirurgi_2025 - 359 - файл

.pdf
Скачиваний:
0
Добавлен:
29.08.2026
Размер:
51 Мб
Скачать
CHAPTER 11 Free Flap Techniques
https://t.me/medicina_free
83
TABLE
11.2
Surgical Principles for Free Flap Transfer for Post-BCT Deformity (*LaP: lumbar artery perforator)
Careful planning of the flap and the recipient vessels
Radiological assessment of the vessels
Excision of damaged tissue – release of scar – re-creation of defect
Careful preparation of the internal mammary vessels
Free flap options – DIEaP, SIEa, TMG, PaP, TDaP, MCFaP, SGaP, IGaP, LaP*
Consideration of muscle sacrifice (overcorrection, atrophy, functional impairment)
Improvement of shaping (based on aesthetic subunits)
Surveillance for cancer
complication rate due to the post-radiotherapy status. Furthermore, every candidate for this technique should undergo a complete history and physical examination by the oncology team before considering an attempt at surgical correction. is examination must be compre­hensive and should encompass the entire body including the breasts. Magnetic resonance imaging of the breast is considered when there is ambiguity in the interpretation of the preoperative mammogram or ultrasound examina­tions.
• e patient is usually marked the day before surgery. e breast size, defect size, and location are estimated.
• Preoperative computed tomographic angiography (CTA) images of the donor site and thoracic region are routinely obtained for perforator mapping and recipient vessel eval­uation. After the ap markings and the grid localization of the perforating vessels are completed according to the anticipated defect, the location of the dominant perfora­tor is conrmed with a unidirectional handheld Doppler.
• Good communication between teams, oncologic and reconstructive, is mandatory.
• It is important to understand the importance of blood
supply to the nipple, placement of skin incisions, and to have an appreciation of breast aesthetics.
• It is equally important that the reconstructive surgeon
appreciate the size and location of the tumor, mar­gin status following excision, and the need to ensure locoregional control.
• Both surgeons should review the radiographic imag-
ing, discuss the anticipated defect location and size, as
well as whether or not the resection will include skin. is will assist with determination of the most appro­priate glandular pedicle required to maintain nipple viability and reshape the mound.
• Anticipate a back-up plan, as occasionally the defect is dierent from that anticipated, and an alternative approach may be required. e incisions for the tumor resection are based on optimizing oncologic excision as well as reconstructing an aesthetically pleasing breast.
• Immediate partial breast reconstruction should be delayed if the surgeon is uncertain about the margins or tumor extension (e.g., tumors with large in-situ compo­nent) despite the preoperative radiological assessment. A delayed immediate reconstruction can still be safely per­formed within a few days following determination of the denitive margin. 
Free Flap Selection
• Flap planning should account for what is missing from the breast skin and parenchyma but also should consider the reduced elasticity in the residual breast tissue. In a free ap reconstruction, an ample and adequate skin paddle should be available with proper planning. Usage of free aps also facilitates orientation of the skin paddle. In our ap plethora, we consider perforator aps to be the gold standard for reconstruction because of their low donor site morbidity.
• Our rst choice is the deep inferior epigastric artery perforator (DIEaP) ap (Video 11.1). It provides an
SECTION II Oncoplastic Breast Surgery – Surgical Techniques
https://t.me/medicina_free
84
ample amount of soft tissue with good color and con­sistency match.
26,27
e supercial inferior epigastric artery (SIEa) ap is a good alternative to the DIEaP ap whenever the direct cutaneous SIE vessels are available and suitable in diameter to perform safe ap transfer.28 erefore, the lower abdominal incision is made rst to assess to availability of the SIE vessels. Because the abdominal donor site can only be used once, its use for partial breast reconstruction makes it unavailable in the future for whole breast reconstruction; therefore, its use should be evaluated very carefully. In some patients, the quantity of abdominal tissue is insucient for total breast reconstruction; thus it may be more suitable for partial breast reconstruction. Another argument sup­portive of the DIEaP ap is that, in body contouring surgery, this tissue is often discarded in a population that is at higher risk for breast cancer compared with the risk of a recurrence in adequately treated breast cancer after BCT.
16,28
e cosmetic result obtained by remov­ing excess tissue from the abdominal area coupled with minimal donor site morbidity and a well-concealed scar make abdominal aps an attractive option for partial breast reconstruction. Some patients view the oppor­tunity to improve their overall appearance as an over­whelming benet of free abdominal perforator ap surgery.
• e transverse myocutaneous gracilis (TMG) ap has become a valuable alternative in absence of availability of abdominal perforator aps.17 For bilateral reconstruc­tion cases, TMG is in particular a good option due to the easy accessibility of both donor sites without need for repositioning. Another option is the Profunda artery perforator (PaP) as well as medial circumex femoral artery perforator (MCFaP) aps that have also been used to reconstruct medial quadrant lumpectomy defects.
29
• Other alternative aps include the superior gluteal artery perforator (SGaP) and inferior gluteal artery perforator (IGaP) aps that may also be considered for post-BCT reconstruction. However, in cases of bilat­eral free ap breast reconstruction, simultaneous SGaP or IGaP reconstruction is time-consuming due to the multiple repositioning of the patient that is required. In our institute, bilateral gluteal ap surgery is usually performed in two stages with a 3–6-month interval between stages.
• A free LD myocutaneous ap has been reported as a sal­vage option for partial medial breast reconstruction after partial loss of a free TRAM ap.30 To limit donor site morbidity, we advocate the use a thoracodorsal artery perforator (TDaP) ap.
22
• Omental aps have been used as a pedicled ap for medial quadrant defects and as a free ap for lateral defects.31 However, due to the diculty of predicting the ap volume, problems in harvesting the ap in patients with previous abdominal surgery, and the lack of a skin island, in our hands the use of this ap for partial breast reconstruction is rare. 
Surgical Technique
• During surgery, all damaged skin, scar, and brotic tissue is excised. Frozen section examination can be requested if recurrence is suspected within the excised tissue. A completion subcutaneous mastectomy can be performed. icker skin aps are developed, with pres­ervation of internal mammary perforators to the medial breast tissues. is maximizes vascularity and thereby minimizes ischemic slough of the previously irradiated skin. We believe that, by performing a completion sub­cutaneous mastectomy, a signicant reduction in the cancer recurrence rate and a more complete release of the postirradiation parenchymal brosis can be achieved. Patients can be reluctant to sacrice the remaining breast tissue or lack the adequate donor tissue for whole breast reconstruction. Another reason to preserve the internal mammary artery perforator (IMaP) vessels is to have the option to perform microanastomosis on these vessels that may be more adequate as recipient vessels based on size and position in certain aps compared with the internal mammary artery and vein.
• e mastectomy skin should be treated with great care, especially after previous radiation. Lengthening an inci­sion is preferable to traumatizing the skin with retractors that may result in skin ap necrosis. If there is any doubt on skin ap viability, peroperative evaluation of perfu­sion can be performed using indocyanine green technol-
32
ogy.
• e recipient vessels should be carefully prepared if irra­diation was delivered specically to the selected region. e internal mammary vessels and their branches are preferred because these vessels usually have less dam­age following radiation when compared with the thora­codorsal vessels. In addition, sparing the thoracodorsal vessels allows for the future use of a pedicled TDaP or LD ap for breast salvage in the case of free ap failure or cancer recurrence.22 e internal mammary vessels are usually prepared without removing rib cartilage.
• After harvesting the free ap and performing the micro­anastomosis, the ap inset is completed with a larger skin paddle than the original breast skin deciency. e ap skin paddle ideally replaces an entire breast aesthetic subunit rather than leaving a small and poorly concealed patch that is very conspicuous when viewed alongside the native breast skin.33 e ap inset and shaping is per­formed with the patient in a seated position to match the cavity. Flap inset in partial reconstructions has some particular challenges that include:
• Variability of the defect location, shape, and size
• Dierent positioning of pedicle and recipient vessels
• Limited skin incision results in a more challenging
ap inset and also inhibits a clear view of the anas­tomoses following inset. e use of an implantable Doppler probe on the vein should be considered when visualization of the pedicle is not possible and the ap has to be inserted through a small incision. A limited
CHAPTER 11 Free Flap Techniques
https://t.me/medicina_free
85
incision with tight skin can result in ap compression and limit venous drainage, which may be dicult to identify when there is only a small skin island.
In aps that include a small segment of muscle, future muscle atrophy and reduction in ap volume should be anticipated; therefore, initial ap volume should be over­sized. In immediate or delayed-immediate reconstruction volume loss due to radiotherapy should also be considered. Other options in achieving symmetry in the future include liposuction and/or lipolling, excision, and/or contralateral reduction. Although irradiated aps are less tolerant for liposuction.
• Donor site closure should be performed with great care.
Closing the abdomen, thigh, or gluteal region should
be performed with the same attention as in an aesthetic
body contouring. Attention to these details will make the
dierence between a nicely healed and well-accepted scar
or result in another stigma and reminder of cancer sur-
gery. 
16
Postoperative Care
• Patients are administered low molecular weight heparin
(LMWH) during the time of relative immobilization for
prophylaxis against deep venous thrombosis.
• Patients typically are discharged from the hospital when the
drains are removed, on average about 5 days after surgery.
• A compression garment is applied over the donor site for
approximately 6 weeks postoperatively.
• When immediate reconstruction is performed, adjuvant
irradiation of the breast, if indicated, can be started at 6
weeks post-reconstruction. Adjuvant chemotherapy can
start 3 weeks postoperatively. is type of reconstruction
rarely results in a delay starting adjuvant therapy. 
used for partial breast reconstruction compared with a ap used for total breast reconstruction.11 A radiated ap how­ever has less tolerance for liposuction.
Surprisingly, more patients express gratitude toward the functional outcome following delayed free ap reconstruc­tion after BCT. Patients report less tightening sensations in their chest wall and reduced arm edema or heaviness follow­ing microvascular ap transfer to the chest. It is postulated that, by releasing the postirradiation scar and importing healthy nonirradiated tissue, subjective improvement is commonly described by patients.
Following partial or total breast reconstruction, patient surveillance proceeds on a regular basis and in the same manner as before the surgical correction. Proper commu­nication between the plastic surgeon, oncologist, and radi­ologist is essential during the follow-up period of these patients. e characteristics of the transferred tissue (fat alone, or muscle and fat combined) and the character­istics of the residual breast tissue (position and amount of retained parenchyma) should be communicated along with any areas of fat necrosis that are identied on postop­erative follow-up. 
Complications and Side Effects
• Free ap failure
• Donor site complications
• Tumor recurrence (ipsi- or contralateral)
• Dicult oncologic follow-up due to fat necrosis which
may lead to more frequent imaging, biopsy of unclear
lesions, and anxiety for the patients
• Mastectomy ap necrosis 
Conclusion
Outcome
When these measures are incorporated into clinical practice, minimal complication rates can be expected. An increase in free ap failure following partial breast reconstruction has not been observed.
Some patients may develop reactive breast edema that subsides after 6–12 months. erefore, if further correc­tion is needed, it should be postponed for at least 6 months after the microvascular reconstruction to allow these reac­tive changes to resolve. A stable aesthetic outcome is usually achieved by 1 year after reconstruction. Improved long-term outcomes are usually observed in patients following com­pletion subcutaneous mastectomy and free ap replacement when compared with patients treated with limited partial reconstruction by pedicled aps, because most of the irradi­ated tissue has been eliminated.
Patient satisfaction scores of 87% have been reported following immediate ap reconstruction of partial mastec­tomy defects.34 e eect of post-lumpectomy radiotherapy causes signicantly fewer deleterious eects on a free ap
e judicious use of free aps for oncoplastic reconstruction expands the possibility for breast conservation.
Post-BCT deformity is addressed in a graded man­ner depending on the degree of deformity, the oncologic requirements, and the patient’s wishes (Table 11.3 Preop- erative evaluation by a plastic surgeon should be included in BCT protocols. It is necessary to increase awareness of possible replacement techniques among breast surgeons and patients.
Free tissue transfer is an important option for treatment of severe post-BCT deformities. Although the indications are limited, when utilized appropriately it oers superior cosmetic and functional results over other techniques. e potential for microvascular failure remains an important caveat of this technique. e surgeon must remember that the abdominal tissue is the optimal choice for whole breast reconstruction of future recurrence or new tumors and, therefore, free tissue transfer should not be performed indis­criminately. Careful patient selection, surgical planning, and technical execution are essential to the success of this procedure. 
SECTION II Oncoplastic Breast Surgery – Surgical Techniques
https://t.me/medicina_free
86
TABLE
11.3
Graded Approach for Post-BCT Deformity
Severe radiotherapy
damage / Difficult
oncologic control /
BRCA 1&2
YES
Mastectomy & Free
flap reconstruction
NO
Breast correction
PTOSIS?
Non-ptotic breast
Replacement
techniques
Ptotic breast
Displacement
techniques
Clinical Cases
e patients discussed in this section gave their consent to the use of their data and photographic material for scientic use and publication.
Case #1
A 51-year-old patient who had a conservative breast treat­ment and multiple previous biopsy procedures in the right breast presented with severe breast deformity and pain. A
ONCOLOGIC
ISSUES?
No oncologic
issues
Fat grafting
Unclear tumor
margin / Extensive
scar tissue
Wide excision &
Pedicled flaps
completion mastectomy was performed with an immedi­ate breast reconstruction using a free DIEaP ap. e post­BCT deformity was restored. A. Preoperative views (photo I & II). B. e plan of surgery: the most damaged breast skin was
planned for excision. A DIEaP ap was designed at the
lower abdominal wall and the mapped perforator was
also marked preoperatively. e microanastomoses were
done to the internal mammary vessels (photo I). C. 2 weeks postoperative view (photo III).
CHAPTER 11 Free Flap Techniques
https://t.me/medicina_free
87
Photo I—preoperative view
Photo III—2 weeks postoperative view 
Case #2
A 47-year-old patient presented for a correction of post­BCT deformity on the medial quadrant of the left breast and a right prophylactic mastectomy with immediate recon­struction. e microanastomoses were done to the internal mammary vessels in both sides. A. Preoperative views (photo IV, V, VI) B. Peroperative views:
Bilateral SIEa ap is planned. SIE vessels are shown with
surgical retractors (photo VII) One SIEa ap harvesting (photo VIII) e donor site after harvesting bilateral SIEa free aps
(photo IX)
C. e results at 2 years postoperative show good breast
symmetry (photo X, XI, XII).
Photo II—preoperative view
SECTION II Oncoplastic Breast Surgery – Surgical Techniques
https://t.me/medicina_free
88
Photo IV—preoperative view
Photo VI—preoperative view
Photo VII—peroperative view
Photo V—preoperative view
Photo VIII—unilateral SIEa flap
Photo IX—peroperative view of abdomen after harvest of both SIEa
https://t.me/medicina_free
flaps
CHAPTER 11 Free Flap Techniques
89
Photo X—2-year postoperative result
Photo XI—2-year postoperative result
Photo XII—2-year postoperative result
SECTION II Oncoplastic Breast Surgery – Surgical Techniques
https://t.me/medicina_free
90
References
1. Veronesi U, Cascinelli N, Mariani L, etal. Twenty-year follow­up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227–1232.
2. Fisher B, Anderson S, Bryant J, etal. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–1241.
3. Arriagada R, Le MG, Rochard F, etal. Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Insitut Gustave-Roussy breast cancer group. J Clin Oncol. 1996;14:1558–1564.
4. Fisher B, Redmond C, Poisson R, et al. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 1989;320:822–828.
5. Poggi MM, Danforth DN, Sciuto LC, etal. Eighteen-year results in the treatment of early breast carcinoma with mastectomy ver­sus breast conservation therapy: the national cancer institute ran­domized trial. Cancer. 2003;98:697–702.
6. Lagendijk M, van Maaren MC, Saadatmand S, et al. Breast con­serving therapy and mastectomy revisited: breast cancer-specic survival and the inuence of prognostic factors in 129,692 patients. Int J Cancer. 2018;142(1):165–175.
7. Zhou X, Li Y. Local recurrence after breast-conserving sur­gery and mastectomy following neoadjuvant chemotherapy for locally advanced breast cancer – a meta-analysis. Breast Care. 2016;11(5):345–351.
8. Killander F, Karlsson P, Anderson H, et al. No breast cancer sub­group can be spared postoperative radiation after breast-conserving surgery. Fifteen-year results from the Swedish breast cancer group randomized trial, swebcg 91 Rt. Eur J Cancer. 2016;67:57–65.
9. Munhoz AM, Aldrighi CM. Determining the optimal approach to breast reconstruction after partial mastectomy. Plast Reconstr Surg. 2006;118:813–814.
10. Negenbron VL, Volders JH, Krekel NMA, etal. Breast-conserving therapy for breast cancer: cosmetic results and options for delayed reconstruction. J Plast Reconstr Aesthet Surg. 2017;70(10):1336–
1344.
11. Losken A, Hamdi M. Partial breast reconstruction: techniques in oncoplastic surgery. Quality Medical Publishing; 2009:61–72, 401–418.
12. Vrouwe SQ, Somogyi RB, Snell L, McMillan C, Vesprini D, Lipa JE. Patient-reported outcomes following breast conservation therapy and barriers to referral for partial breast reconstruction. Plast Reconstr Surg. 2018;141(1):1–9.
13. Clough KB, Cuminet J, Fitoussi A, etal. Cosmetic sequelae after conservative treatment for breast cancer: classication and results of surgical correction. Ann Plast Surg. 1998;41:471–481.
14. Hamdi M, Woli J, Van Landuyt K. Partial mastectomy recon­struction. Clin Plast Surg. 2007;34:51–62.
15. Kronowitz SJ, Feledy JA, Hunt KK, etal. Determining the opti­mal approach to breast reconstruction after partial mastectomy. Plast Reconstr Surg. 2006;117:1–11.
16. Spiegel AJ, Eldor L. Partial breast reconstruction with mini supercial inferior epigastric artery and mini deep inferior epi­gastric perforator aps. Ann Plast Surg. 2010;65(02):147–154.
17. McCulley SJ, Macmillan RD, Rasheed T. Transverse upper graci­lis (TUG) ap for volume replacement in breast conserving sur­gery for medial breast tumours in small to medium sized breasts. J Plast Reconstr Aesthet Surg. 2011;64(08):1056–1060.
18. Berrino P, Campora E, Santi P. Postquadrantectomy breast deformities: classication and techniques of surgical correction. Plast Reconstr Surg. 1987;79:567–571.
19. Clough K, Kroll S, Audretsch W. An approach to the repair of partial mastectomy defects. Plastic and Reconstructive Surgery. 1999;104(2):409–420.
20. Kroll SS, Schusterman MA, Reece GP, etal. Breast reconstruc­tion with myocutaneous aps in previously irradiated patients. Plast Reconstr Surg. 1994;93:460–469.
21. Chang DW, Kroll SS, Dackiw A, etal. Reconstructive manage­ment of contralateral breast cancer in patients who previously underwent unilateral breast reconstruction. Plast Reconstr Surg. 2001;108:352–358.
22. Hamdi M, Van Landuyt K, Monstrey S, etal. Pedicled perfora­tor aps in breast reconstruction: a new concept. Br J Plast Surg. 2004;57:531–539.
23. Smith ML, Molina BJ, Dayan E, et al. Dening the role of free aps in partial breast reconstruction. J Reconstr Microsurg. 2018;34(03):185–192.
24. Hamdi M, Van Landuyt K, Ulens S, Van Hedent E, Roche N, Monstrey S. Clinical applications of the superior epigastric artery perforator (seap) ap: anatomical studies and preoperative per­forator mapping with multidetector CT. J Plast Reconstr Aesthet Surg. 2009;62(9):1127–1134.
25. Nahabedian MY, Patel KM, Kaminsky AJ, Cocilovo C, Miraliak­bari R. Biplanar oncoplastic surgery: a novel approach to breast conservation for small and medium sized breasts. Plast Reconstr Surg. 2013;132(05):1081–1084.
26. Blondeel PN. One hundred free DIEP ap breast reconstruc­tions: a personal experience. Br J Plast Surg. 1999;52:104–111.
27. Hamdi M, Weiler-Mitho E, Webster M. Deep inferior epigas­tric perforator ap in breast reconstruction: experience with the rst 50 aps. Plast Reconstr Surg. 1999;103:86–95.
28. Rizzuto RP, Allen RJ. Reconstruction of a partial mastectomy defect with the supercial inferior epigastric artery (SIEA) ap. J Reconstr Microsurg. 2004;20:441–445.
29. Izumi K, Fujikawa M, Tashima H, et al. Immediate reconstruc­tion using free medial circumex femoral artery perforator aps after breast-conserving surgery. J Plast Reconstr Aesthet Surg. 2013;66:1528–1533.
30. Serletti JM, Higgins J, Carras AJ. Free latissimus dorsi myocuta­neous ap for secondary breast reconstruction after partial loss of a TRAM ap. Plast Reconstr Surg. 1997;100(03):690–694.
31. Zaha H. Oncoplastic volume replacement technique for the upper inner quadrant using the omental ap. Gland Surg. 2015;4(03):263–269.
32. Moyer HR, Losken A. Predicting mastectomy skin ap necrosis with indocyanine green angiography: the gray area dened. Plast Reconstr Surg. 2012;129(5):1043–1048.
33. Spear SL, Davison SP. Aesthetic subunits of the breast. Plast Reconstr Surg. 2003;112:440–447.
34. Yang JD, Kim MC, Lee JW, et al. Usefulness of oncoplastic volume replacement techniques after breast conserving surgery in small to moderate-sized breasts. Arch Plast Surg. 2012;39(05):489–496.
Breast Augmentation Technique
https://t.me/medicina_free
(Biplanar) for Oncoplasty
YOAV BARNEA
Conflict of Interest Statement
No funding was provided for this chapter. Dr. Barnea is a speaker for Johnson Medical. 
Introduction
Breast conservation therapy (BCT) has become the main­stay in surgical breast oncology practice and is now a rou­tine technique for the treatment of early-stage cancers.1 Improvements in diagnostic technology and mammographic screening as well as increased use of preoperative local and systemic therapies have extended the indications for BCT, with reported rates of 58% in the UK and 60–75% in the United States. sive tissue resection consisting of lumpectomy with tumor­free margins followed by radiation therapy, major contour irregularities have been observed following these proce-
4-6
dures. in 5–40% of patients. from the lumpectomy defect with added postoperative radiation eects may sometimes lead to substantial distor­tions in breast shape and size as well as nipple position. e management of breast deformities secondary to BCT in such cases can pose considerable diculties, particularly when operating in a radiated eld with poor tissue com­pliance. Several oncoplastic breast surgery techniques were introduced in an attempt to optimize the balance between the risk of local recurrence and the cosmetic outcome in
7-11
BCT. replacement or tissue rearrangement involve a wider local excision while achieving enhanced breast shape and sym­metry, and reduced surgical dead space.
Patients with small volume breast and relative large lumpectomy volume are at risk of developing severe breast deformity and breast asymmetry following BCT, thus pre­senting a unique surgical challenge. can be used to replace the volume loss in small-breasted patients,10 but many of them are reluctant to undergo this
2,3
Although BCT has enabled a less exten-
Poor cosmetic results of BCT have been reported
7-11
e surgical dead space created
7-11
e combined plastic surgery techniques of tissue
7-11
10-12
Regional aps
procedure due to additional scarring and morbidity, lead­ing them to forgo oncoplastic reconstruction altogether or to undergo mastectomy and immediate reconstruction. e use of a prosthetic device for volume replacement in small breasts may seem appealing, but it has been largely rejected on the basis of studies that cited high complica­tion rates following radiation therapy.
16,17
One such study showed that subcutaneous implant placement in the imme­diate setting led to high incidences of capsular contracture and other complications.17 Nevertheless, there is reason to believe that with increasing surgical expertise and improved radiation delivery methods, implant-based procedures in patients planned for radiation therapy might have a better outcome compared with earlier experience.
18-21
selection of the radiotherapy technique can reportedly help to improve the dose distribution and cause fewer radiation­induced side eects.
22-24
Recent studies have advocated immediate implant-based reconstruction for patients receiv­ing post-mastectomy radiotherapy, especially those who may not be candidates for autologous reconstruction. Moreover, patients with previous breast augmentation who later undergo BCT were reported to have good to excellent outcomes following their radiation treatment.
25,26
With growing experience and renement in breast tis­sue rearrangement techniques, together with implant-based reconstruction and modern radiation therapy methods, more consistent results may be oered to breast cancer patients with small volume breasts who are considering BCT by means of the oncoplastic biplanar breast augmen­tation technique.
12,27
is technique consists of immediate local glandular tissue rearrangement after a lumpectomy procedure and the use of bilateral subpectoral breast aug­mentation of dierent size and projection implants to compensate for the lumpectomy-caused volume loss. e technique aims to achieve immediate correction of shape and volume before radiotherapy without the added morbid­ity associated with the use of autologous aps or delayed BCT reconstructions.
12,27
13-15
Judicious
22-24
91
SECTION II Oncoplastic Breast Surgery – Surgical Techniques
https://t.me/medicina_free
92
A
Fig. 12.1 (A) Illustrations of the OBA technique. Breast tumor in the upper pole of the breast. (B) A radial
incision was performed over the tumor area, and the tumor was removed with adequate margins. (C) Tissue approximation was done using parenchymal advancement with limited undermining of the parenchyma or the skin flaps.
B
Patient Selection
Patient selection is processed through the multidisciplinary breast team, after reviewing all relevant breast imaging studies and after planning the surgical scars and resec­tion area based on tumor size and location. It is essential to ensure that all patients are motivated to enhance their breasts, and that they understand that the possible eects of radiation therapy on the implant range from negligible to severe capsular contracture and breast deformity. Cur­rently, we have no way to predict which patient will do well after radiation. 
Indications and Contraindications
Indications for the oncoplastic biplanar breast augmenta­tion technique include patients scheduled for BCT who have small and non-ptotic breasts (bra cup A–B), with rel­atively large tumors that could not be addressed by local tissue rearrangement alone. Tumor size should be smaller than 25% of the total breast volume. Preferences for tumor location include the upper pole of the breast, above a hori­zontal line at the lower areolar position. Lower-positioned tumors, especially near the inframammary fold area, are close to the pocket of the implant, thus making it dicult to dissect separate tumor implant pockets. For these selected cases of lower-pole breast tumors, an acellular dermal matrix (ADM) graft can be used to reinforce the lower pole of the breast and improve the separation between the implant and the lumpectomy pockets.
C
Patients with previous breast augmentation are also can­didates for this technique. e implant on the aected side is exchanged for a larger one in order to compensate for the lumpectomy volume loss. Implants in a previous subglan­dular position are exchanged for a subpectoral dual plane pocket.
Patients with tumor involvement of the nipple–areolar complex (NAC), distant metastasis, or tumors growing into the chest wall or skin (oncologic stage T4) are not candi­dates for this technique. 
Operative Approach (Video 12.1)
e patient is marked in a manner similar to a breast aug­mentation procedure, with the addition of the area of the planned lumpectomy. After prepping and draping the supine patient, the breast surgeon performs a wire-guided lumpectomy (Fig. 12.1A). e incision of choice is periare­olar, with an incision extension if needed. For cases in which the tumor is not centrally located, the surgeon performs a radial or an arched incision over the tumor area. e tumor is removed, marked, weighed, and sent to mammography and pathology. Additional tissue extensions are taken from the tumor bed, and the space is marked with metal hemo­static clips (Fig. 12.1B). e lymph node procedure is per­formed from a separate axillary incision.
After irrigation and careful hemostasis, the tumor bed is inspected and tissue approximation is performed by local tis­sue advancement. Further limited undermining of the breast parenchyma or the skin aps is occasionally necessary before
Соседние файлы в папке @xirurgi_2025